skip to main content

Head and Neck Cancer

Rogel Cancer Center joins top cancer centers in call to get cancer-preventing HPV vaccination back on track

National Cancer Institute-designated cancer centers and leading cancer organizations issued a joint statement urging the nation’s physicians, parents and young adults to get back on track with the human papillomavirus, or HPV, vaccination.

HPV Behind Increase In Head and Neck Cancers in Taiwan, Study Finds

The findings suggest policies and public health interventions in Taiwan could help prevent HPV-driven cancers.

New $2.9M grant will look at impact of HPV on head and neck cancer

A team of researchers from the Rogel Cancer Center have received a $2.9 million grant from the National Cancer Institute to look at how HPV behaves in patients with head and neck cancer and how that could help identify who might benefit from less-aggressive treatment.

University of Michigan Awarded $3.8 Million for Cancer Research

This 'Cancer Moonshot' research grant has been awarded to the University of Michigan's Dental School. Dr. Yu Leo Lei, a Rogel Cancer Center member, will lead researchers from U-M, other universities on new cancer prevention therapies.

Pages